RO6874281 is a bispecific IL2 immunocytokine which targets cancer associated fibroblasts via binding to FAP and has shown potent anti-tumor activity in melanoma, neuroblastoma and colon carcinoma models [141]. Here, FAP is linked to neoplasm.